...
首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation
【24h】

The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation conditioning prior to allogeneic stem cell transplantation

机译:同种异体干细胞移植前体外造血,喷喷他汀和降低剂量的全身照射条件后,造血细胞移植的合并症指数和存活率

获取原文
获取原文并翻译 | 示例
           

摘要

Hematopoietic-cell-transplantation-specific-comorbidity-index (HCT-CI) has been reported as a predictor of survival in allogeneic-transplant recipients; however its validity has recently been challenged. We evaluated the association of HCT-CI with survival of transplant recipients who underwent reduced-intensity-conditioning (RIC) with photopheresis, pentostatin, and total-body-irradiation. Median age of 103 patients selected was 55 years. Most patients (58.3%) had high (≥3) HCT-CI. Median OS was 298 days. Age, disease-type, disease-status, HCT-CI correlated with survival on bivariate analysis. On multivariate analysis, only HCT-CI was significantly associated with OS (low HCT-CI HR = 0.29, CI 0.091-0.886; intermediate HCT-CI HR = 0.41, CI 0.226-0.752). Our findings suggest HCT-CI as an independent predictor of survival in the setting of RIC transplants.
机译:据报道,造血细胞移植特异性合并症指数(HCT-CI)可作为异基因移植受体存活的预测指标。但是,其有效性最近受到了挑战。我们评估了HCT-CI与通过光穿刺术,喷喷抑素和全身照射进行强度降低条件(RIC)的移植接受者的存活率之间的关系。选择的103名患者的中位年龄为55岁。大多数患者(58.3%)的HCT-CI高(≥3)。 OS中位数为298天。在双变量分析中,年龄,疾病类型,疾病状态,HCT-CI与生存率相关。在多变量分析中,仅HCT-CI与OS显着相关(低HCT-CI HR = 0.29,CI 0.091-0.886;中级HCT-CI HR = 0.41,CI 0.226-0.752)。我们的发现表明,HCT-CI是RIC移植中生存的独立预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号